<DOC>
	<DOCNO>NCT02706821</DOCNO>
	<brief_summary>The investigator perform 8-week , randomize , double-blind , placebo-controlled crossover human trial evaluate efficacy safety persimmon leaf extract blood glucose . The investigator measure change diabetes associate parameter , include fast blood glucose , postprandial blood glucose , insulin , C-peptide HbA1c .</brief_summary>
	<brief_title>Anti-diabetic Effects Persimmon Leaf Extract</brief_title>
	<detailed_description />
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Age 2075 year Fasting blood glucose ( FPG ) 100~140 mg/dL postprandial blood glucose ( PPG ) 140~250 mg/dL FPG 140 mg/dL 2h PPG 200 mg/dL Type 1 diabetes HbA1c 9.0 % treatment corticosteroid within past 4 week cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>prediabetes</keyword>
	<keyword>blood glucose</keyword>
	<keyword>clinical trial</keyword>
</DOC>